The Rogosin Institute

The Rogosin Institute was established in NewYork City in 1983 as an independent, not-for-profit institution for research, treatment, and education in kidney disease (including dialysis and transplantation) and cardiovascular disease secondary to cholesterol and other lipid disorders.  Rogosin’s history can be traced to 1955 when the Cardiorenal Laboratory at the Second (Cornell) Medical Division of Bellevue Hospital in NewYork City was created and became the predecessor for ensuing kidney programs.

Rogosin is affiliated with NewYork-Presbyterian Hospital, Weill Cornell Medical College and is a member of NewYork-Presbyterian Healthcare System.  All our physicians have appointments in NewYork-Presbyterian Hospital and Weill Cornell Medical College.

First Hemodialysis

In 1957, Albert L. Rubin, MD, and his team performed the first hemodialysis in the metropolitan area as a treatment for kidney failure. In 1962, the unit became known as the Renal Laboratory and moved to The New York Hospital-Cornell Medical Center. There, it expanded to the Rogosin Renal Laboratories, named in honor of Israel Rogosin (1886-1971), an American textile industrialist and philanthropist who was a generous benefactor of the New York Hospital-Cornell Medical Center (NYH-CMC).  

First Kidney Transplant

The first kidney transplant in the metropolitan area was performed by the renal group in 1963. Following continued growth of the kidney disease program, NYH-CMC was designated by the Department of Health of the State of New York as a Regional Kidney Disease Center in 1968 and the laboratories then formally became known as the Rogosin Kidney Center. In 1983, with a growing expansion of activities into research and treatment of cardiovascular disease and cancer of the kidney, The Rogosin Institute was founded as an independent corporate entity with Rogosin Kidney Center as one of its several components.

In 1988, many of The Rogosin Institute’s facilities, located in different areas of The New York Hospital-Cornell Medical Center complex, were brought together in The New York Hospital’s Helmsley Medical Tower at 70th Street and York Avenue.  

Transplant Milestones

The 1000th kidney transplant was performed in 1984, with the 2000th procedure conducted in 1999. The milestone 3000th kidney transplant was performed in 2007.

Expansion

During the 1990s continued growth and expansion occurred.  The Rogosin Institute has additional clinical facilities in Queens and Brooklyn and research facilities are located at The Rockefeller University and in Xenia, Ohio.

Recent expansions include the initiation of a Home Nocturnal Hemodialysis training and treatment program in 2001; and the 2002 launch of the Susan R. Knafel Polycystic Kidney Disease Center at the Dreyfus Clinic, one of the only centers for treatment of polycystic kidney disease in the Northeast area.

The Rogosin Institute’s Iris and B. Gerald Cantor Clinical Laboratory, located at The Rockefeller University, provides general and specialized laboratory tests in all areas.

The clinical research program for cancer, under the direction of Barry Smith, M.D., Ph.D., began investigating treatments in patients in 2006.

Patient Care Facilities

Within NewYork-Presbyterian Hospital/Weill Cornell, inpatient facilities include The Rogosin Institute Wing for patients requiring hospitalization for kidney disease related problems and kidney transplantation; and The Rogosin Institute Ralph J. Bunche Dialysis and Apheresis Center for patients undergoing intensive care hemodialysis.  The Rogosin Institute also has access to NewYork-Presbyterian Hospital/Weill Cornell’s Clinical Research Center (CRC) and The Rockefeller University’s Clinical Research Center for inpatient studies.